2023 CIBERNED WEBINAR SERIES Preclinical development of the cannabigerol derivative VCE-003.2 as a new neuroprotective agent in Parkinson's disease

Date: 14/12/2023 (15:30)

Title: “Preclinical development of the cannabigerol derivative VCE-003.2 as a new neuroprotective agent in Parkinson's disease”

Speaker: María Gómez (Assistant Professor). Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense de Madrid

CIBERNED group:   Javier Fernández - Program 2

Webinar Access: https://teams.microsoft.com/l/meetup-join/19%3ameeting_NmRiZTBhMWUtZGJlNC00ODcwLWJmMTUtNjY3MGI4ODkwNGNl%40thread.v2/0?context=%7b%22Tid%22%3a%22a0966eb2-54c2-499b-b26f-0830c2531faf%22%2c%22Oid%22%3a%22148e56be-0aea-4c41-93c3-1ef8acc87bdd%22%7d